The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer

被引：155
|
作者：
Jordheim, Lars Petter [1 ,2 ]
Seve, Pascal [2 ,3 ]
Tredan, Olivier [5 ]
Dumontet, Charles [2 ,4 ]
机构：
[1] Univ Lyon 1, Fac Med Rockefeller, Lab Cytol Analyt, INSERM,U590, F-69008 Lyon, France
[2] Lyon Univ, Lyon, France
[3] Hosp Civils Lyon, Dept Internal Med, Lyon, France
[4] Hosp Civils Lyon, Hematol Lab, Lyon, France
[5] Ctr Leon Berard, Dept Med Oncol, F-69373 Lyon, France
来源：
LANCET ONCOLOGY | 2011年 / 12卷 / 07期
关键词：
CELL LUNG-CANCER; MESSENGER-RNA EXPRESSION; HUMAN PANCREATIC-CANCER; GEMCITABINE-BASED CHEMOTHERAPY; CHROMOSOME SEGMENT 11P15.5; ANTITUMOR-ACTIVITY; MOLECULAR MARKERS; SINGLE NUCLEOTIDE; ERCC1; EXPRESSION; RANDOMIZED-TRIAL;
D O I：
10.1016/S1470-2045(10)70244-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The large subunit of human ribonucleotide reductase, RRM1, is involved in the regulation of cell proliferation, cell migration, tumour and metastasis development, and the synthesis of deoxyribonucleotides for DNA synthesis. It is also a cellular target for the chemotherapeutic agent, gemcitabine. RRM1 has been studied in a large number of patients with different types of cancer, such as non-small-cell lung cancer, pancreatic cancer, breast cancer, and biliary tract cancer, to establish its prognostic or predictive value when patients were treated with gemcitabine, and mRNA expression and genetic variants as determined by genotyping have in some cases been associated with clinical outcome of patients with cancer. Here, we review preclinical and clinical studies of RRM1 assessment and discuss the further steps in the development of this clinically pertinent biomarker.
引用
收藏
页码：693 / 702
页数：10
相关论文
共 50 条
  • [11] N-ethylmaleimide modulates gemcitabine effect on ribonucleotide reductase M1 subunit (RRM1)
    Chen, Zhengming
    Bepler, Gerold
    CANCER RESEARCH, 2011, 71
  • [12] Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma
    Sagawa, Morihiko
    Ohguchi, Hiroto
    Harada, Takeshi
    Samur, Mehmet K.
    Tai, Yu-Tzu
    Munshi, Nikhil C.
    Kizaki, Masahiro
    Hideshima, Teru
    Anderson, Kenneth C.
    CLINICAL CANCER RESEARCH, 2017, 23 (17) : 5225 - 5237
  • [13] Excision repair cross complementing group 1 (ERCC1) and regulatory subunit of Ribonucleotide Reductase (RRM1) as prognostic and predictive markers for ovarian cancer.
    Zhou, Jun
    Ahmed, Quratulain
    Chen, Wei
    Li, Xin
    Morris, Robert
    Ali-Fehmi, Rouba
    Bepler, Gerold
    CANCER RESEARCH, 2013, 73 (08)
  • [14] A Single Conserved Residue Mediates Binding of the Ribonucleotide Reductase Catalytic Subunit RRM1 to RRM2 and Is Essential for Mouse Development
    Specks, Julia
    Lecona, Emilio
    Lopez-Contreras, Andres J.
    Fernandez-Capetillo, Oscar
    MOLECULAR AND CELLULAR BIOLOGY, 2015, 35 (17) : 2910 - 2917
  • [15] Prognostic value of ribonucleotide reductase subunit M1 (RRM1) in non-small cell lung cancer: A meta-analysis
    Zhu, Cui-min
    Lian, Xiang-yao
    Bi, Ying-hui
    Hu, Chan-chan
    Liang, Yun-wei
    Li, Qing-shan
    CLINICA CHIMICA ACTA, 2018, 485 : 67 - 73
  • [16] The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1)
    Vena, Francesca
    Li Causi, Eleonora
    Rodriguez-Justo, Manuel
    Goodstal, Samantha
    Hagemann, Thorsten
    Hartley, John A.
    Hochhauser, Daniel
    CLINICAL CANCER RESEARCH, 2015, 21 (24) : 5563 - 5577
  • [17] The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia
    Chatzidavid S.
    Kontandreopoulou C.-N.
    Diamantopoulos P.T.
    Giannakopoulou N.
    Katsiampoura P.
    Stafylidis C.
    Dryllis G.
    Kyrtsonis M.-C.
    Dimou M.
    Panayiotidis P.
    Viniou N.-A.
    Clinical Hematology International, 2023, 5 (2-3) : 92 - 100
  • [18] RRM1 - a predictive and prognostic marker for patients with NSCLC
    Bepler, Gerold
    Zheng, Zhong
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S167 - S167
  • [19] Targeting the Large Subunit of Human Ribonucleotide Reductase for Cancer Chemotherapy
    Wijerathna, Sanath R.
    Ahmad, Md. Faiz
    Xu, Hai
    Fairman, James W.
    Zhang, Andrew
    Kaushal, Prem Singh
    Wan, Qun
    Kiser, Jianying
    Dealwis, Chris G.
    PHARMACEUTICALS, 2011, 4 (10): : 1328 - 1354
  • [20] SNPS IN RIBONUCLEOTIDE REDUCTASE GENES RRM1 AND RRM2 ARE ASSOCIATED WITH MRNA EXPRESSION AND RESPONSE TO NUCLEOSIDE ANALOGS-BASED CHEMOTHERAPY
    Mitra, A. K.
    Ghosh, T. Mitra
    Feldberg, T. J.
    Pounds, S.
    Cao, X.
    Lamba, J. K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S63 - S63
12345